Amneal Pharmaceuticals, Inc (AMRX) insider trading
Every open-market stock purchase and sale by Amneal Pharmaceuticals, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $2.6M over the last 12 months (3 sales). No open-market buys.
- Last insider buy: Gautam Patel (Director), $211K, 4 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $2.6M (3 sales). Last close $13.75 on Jun 4, 2026.
Recent AMRX insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| May 11, 2026 | Deborah M. Autor (Director) | Sold | $451K |
| May 7, 2026 | Shlomo Yanai (Director) | Bought (not open market) | — |
| May 7, 2026 | Gautam Patel (Director) | Bought (not open market) | — |
| May 7, 2026 | Deborah M. Autor (Director) | Bought (not open market) | — |
| May 7, 2026 | J Kevin Buchi (Director) | Bought (not open market) | — |
| May 7, 2026 | Jeffrey P. George (Director) | Bought (not open market) | — |
| May 7, 2026 | John Kiely (Director) | Bought (not open market) | — |
| May 7, 2026 | Ted C Nark (Director) | Bought (not open market) | — |
| May 7, 2026 | Paul M Meister (Director) | Bought (not open market) | — |
| May 6, 2026 | John Kiely (Director) | Bought (not open market) | — |
| May 6, 2026 | Shlomo Yanai (Director) | Bought (not open market) | — |
| May 6, 2026 | Paul M Meister (Director) | Bought (not open market) | — |
| May 6, 2026 | Ted C Nark (Director) | Bought (not open market) | — |
| May 6, 2026 | Gautam Patel (Director) | Bought (not open market) | — |
| May 6, 2026 | J Kevin Buchi (Director) | Bought (not open market) | — |
| May 6, 2026 | Deborah M. Autor (Director) | Bought (not open market) | — |
| May 6, 2026 | Jeffrey P. George (Director) | Bought (not open market) | — |
| Mar 4, 2026 | Chirag K. Patel (CEO) | Sold (not open market) | $503K |
| Mar 4, 2026 | Chintu Patel (CEO) | Sold (not open market) | $385K |
| Mar 4, 2026 | Tasos Konidaris (CFO) | Sold (not open market) | $293K |
| Mar 4, 2026 | Andrew S Boyer (President) | Sold (not open market) | $255K |
| Mar 4, 2026 | Nikita Shah (President) | Sold (not open market) | $239K |
| Mar 4, 2026 | Jason B. Daly (C-suite exec) | Sold (not open market) | $207K |
| Mar 4, 2026 | Chintu Patel (CEO) | Bought (not open market) | — |
| Mar 4, 2026 | Tasos Konidaris (CFO) | Bought (not open market) | — |
Who's trading AMRX
- Deborah M. Autor, Director: sold $451K (1 sale), last May 11, 2026
- Shlomo Yanai, Director: other filings, last May 7, 2026
- J Kevin Buchi, Director: other filings, last May 7, 2026
- Jeffrey P. George, Director: other filings, last May 7, 2026
- John Kiely, Director: other filings, last May 7, 2026
- Paul M Meister, Director: other filings, last May 7, 2026
- Ted C Nark, Director: sold $586K (1 sale), last May 7, 2026
- Gautam Patel, Director: other filings, last May 7, 2026
- Tasos Konidaris, CFO: other filings, last Mar 4, 2026
- Nikita Shah, President: sold $1.6M (1 sale), last Mar 4, 2026
- Chintu Patel, CEO: other filings, last Mar 4, 2026
- Andrew S Boyer, President: other filings, last Mar 4, 2026
- Chirag K. Patel, CEO: other filings, last Mar 4, 2026
- Jason B. Daly, C-suite exec: other filings, last Mar 4, 2026
Get free alerts when an insider at Amneal Pharmaceuticals, Inc files a new trade →